• Applications & Products
    • Applications
    • Products
  • Media Formulation
  • About InVitria
  • News & Blog
  • Contact Us
  • Terms
  • Privacy
  • Sitemap
Performance. Defined.
  • 1-800-916-8311 or Email Us
  • iconMy Account
  • iconView Cart
  • Applications & Products
    • Applications
      • Gene Therapy
      • Cell Therapy
      • T-Cell Immunotherapy
      • Vaccine Production
      • Antibody Production
      • Final Formulation
      • Food Science
    • Product Types
      • Blood-Free Cell Culture Media
      • Cell Culture Components
      • Insulin-Transferrin Supplements
      • Recombinant Albumin
      • Recombinant Transferrin
      • Recombinant Human Lysozyme
      • Recombinant Human Interleukins
    • Products
      • Cellastim S® – Recombinant human albumin
      • Exbumin® – Recombinant human albumin excipient
      • Optibumin® 20 – Recombinant human albumin
      • Optibumin® 25 – Recombinant human albumin
      • Optiferrin® – Recombinant human transferrin
      • Lacromin® – Recombinant human holo lactoferrin
      • ITS AF – Blood-free cell culture media supplement
      • ITSE + A – Blood-free cell culture media supplement
      • ITSE Animal-Free® – Blood-free cell culture media supplement
      • Lysobac® – Recombinant human lysozyme
      • OptiLeukin 2 – Recombinant human IL-2
      • LIF – Leukemia Inhibitory Factor
      • OptiVERO® – Chemically-defined complete VERO media
  • About InVitria
  • News & Blog
  • Contact Us
  • Knowledge Base
  • Applications
  • Products
  • Contact Us
  • Home
  • InVitria Expands Operations to Anschutz Medical Campus in the Denver Metro Area

InVitria Expands Operations to Anschutz Medical Campus in the Denver Metro Area

Published on 3 August 2018

Scott Deeter

To enable further growth and expansion of our team and operations, InVitria is moving our Colorado location to Anschutz Medical Campus. The larger facility will help the InVitria team as we continue to expand our product line of blood-free supplements, components and media to facilitate the approval of life changing medicines.

InVitria at Anschutz Medical Campus in Denver

A Biotech Research & Education Hub

Located in the Denver metro area near the Rocky Mountains, the 230-acre Anschutz Medical Campus offers over ten million square feet of newly-built patient care, research and education facilities. This Denver area has become a rapidly growing area for biopharma and is ranked #13 in the country based on life sciences employment, venture capital funding and several other criteria. InVitria will be moving into the Bioscience 1 building effective July 30th 2018.

“The Anschutz Medical Campus is an ideal location for our Colorado facility.” says Scott Deeter, CEO of InVitria, “there’s a deep and growing biotech talent pool in the area that understands the industry and I’m excited that this move will foster more opportunities for future university research collaborations and strategic partnerships within biopharma in Denver.”

Continuing Expansion in Kansas

InVitria_0902-361309-edited

InVitria is also expanding operations at our location in Junction City, Kansas. The expansion of our facilities will help us as we develop our custom blood-free media formulation services. These services will allow us to provide a unique blood-free complete media formulation that is designed to be consistent, defined and recombinant – throughout a client’s specific manufacturing process and methods.

These expansions in Kansas and the relocation of our Colorado office to the Anschutz Medical Campus will help InVitria as we strive to become the global leader for blood-free components, supplements and media. For more information on our recent move and what this means for our future research efforts, please visit www.invitria.com or contact us by emailing info@invitria.com.  

Start New Search

Quick Search Links

Application:

Antibody Production

Cell Therapy

Final Formulation

Food Science

Gene Therapy

T-Cell Immunotherapy

Vaccine Production

Product Category:

Cell Culture Supplements

Albumin

Cell Culture Media

Interleukins

Lactoferrin

LIF

Lysozyme

Single Components

Transferrin

Product:

Exbumin® – Recombinant human albumin excipient

ITS AF™ – Blood-free cell culture media supplement

ITSE + A™ – Blood-free cell culture media supplement

ITSE Animal-Free® – Blood-free cell culture media supplement

Lacromin® – Recombinant human holo-lactoferrin

OptiLeukin™ 2 – Recombinant human interleukin-2

OptiVERO®

Cellastim® S – Recombinant human albumin

Optibumin ® 20 – Recombinant human albumin

Optibumin ® 25 – Recombinant human albumin

Optiferrin® – Recombinant human transferrin

Leukemia Inhibitory Factor

Lysobac® – Recombinant human lysozyme

Document Type:

Application Notes

Blog

Catalog

Data Sheets

Interviews

Journal Articles (DOI Links)

News

Posters

Product Brochures

Product Specifications

SDS

Use Guidelines

Webinar

White Papers

Cell Line:

B Lymphocyte

CHO

ESC

HEK293

Hematopoetic Stem Cells

Hybridoma

iPSC

Mesenchymal Stem Cells

Natural Killer Cells

Neural Stem Cells

T Lymphocyte

VERO

  • 2718 Industrial Drive • Junction City, KS 66441
  • 800-916-8311
  • © 2025 InVitria

    • Terms
    • Privacy
    • Sitemap